Optimization for Regorafenib in HCC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine T Frenette, MD
Scripps MD Anderson Cancer Center
Principal Investigator - Madappa Kundranda, MD
Banner MD Andersen Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Va Long Beach Health System
Long Beach, California, United States
- Tulane University
New Orleans, Louisiana, United States
- Henry Ford Health Systems
Detroit, Michigan, United States
- Cancer and Hematology Centers of Western Michigan
Grand Rapids, Michigan, United States
- Saint Louis University
St Louis, Missouri, United States
- Comprehensive Cancer Centers of Nevada
Henderson, Nevada, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jan 2021
- Primary completion
- 13 Oct 2021
- Completion
- 10 Dec 2021
- Last update posted
- 30 Dec 2021
- Registered enrollment
- 7
- Registry id
- NCT04476329
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.